Perivascular adipose tissue (PVAT) plays a paracrine role in regulating vascular tone. We hypothesize that PVAT undergoes adaptative mechanisms during initial steps of diet-induced obesity (DIO) which contribute to preserve vascular function. Four-week-old male C57BL/6J mice were assigned either to a control [low-fat (LF); 10% kcal from fat] or to a high-fat diet (HF; 45% kcal from fat). After 8 wk of dietary treatment vascular function was analyzed in the whole perfused mesenteric bed (MB) and in isolated mesenteric arteries cleaned of PVAT. Relaxant responses to acetylcholine (10 Ϫ9 -10 Ϫ4 M) and sodium nitroprusside (10 Ϫ12 -10 Ϫ5 M) were significantly ameliorated in the whole MB from HF animals. However, there was no difference between HF and LF groups in isolated mesenteric arteries devoid of PVAT. The enhancement of relaxant responses detected in HF mice was not attributable to an increased release of nitric oxide (NO) from the endothelium nor to an increased sensitivity and/or activity of muscular guanilylcyclase. Mesenteric PVAT of HF animals showed an increased bioavailability of NO, detected by 4,5-diaminofluorescein diacetate (DAF2-DA) staining, which positively correlated with plasma leptin levels. DAF-2DA staining was absent in PVAT from ob/ob mice but was detected in these animals after 4-wk leptin replacement. The main finding in this study is that adaptative NO overproduction occurs in PVAT during early DIO which might be aimed at preserving vascular function. (Endocrinology 151: 0000 -0000, 2010) O besity is an independent risk factor for the development of endothelial dysfunction and vascular disease. Indeed, some studies ensure that the probability of suffering from vascular diseases is four times higher in obese people (body mass index Ͼ30 kg/m 2 ) than in normal-weight people (body mass index Յ25 kg/m 2
Perivascular adipose tissue (PVAT) plays a paracrine role in regulating vascular tone. We hypothesize that PVAT undergoes adaptative mechanisms during initial steps of diet-induced obesity (DIO) which contribute to preserve vascular function. Four-week-old male C57BL/6J mice were assigned either to a control [low-fat (LF); 10% kcal from fat] or to a high-fat diet (HF; 45% kcal from fat). After 8 wk of dietary treatment vascular function was analyzed in the whole perfused mesenteric bed (MB) and in isolated mesenteric arteries cleaned of PVAT. Relaxant responses to acetylcholine (10 Ϫ9 -10 Ϫ4 M) and sodium nitroprusside (10 Ϫ12 -10 Ϫ5 M) were significantly ameliorated in the whole MB from HF animals. However, there was no difference between HF and LF groups in isolated mesenteric arteries devoid of PVAT. The enhancement of relaxant responses detected in HF mice was not attributable to an increased release of nitric oxide (NO) from the endothelium nor to an increased sensitivity and/or activity of muscular guanilylcyclase. Mesenteric PVAT of HF animals showed an increased bioavailability of NO, detected by 4,5-diaminofluorescein diacetate (DAF2-DA) staining, which positively correlated with plasma leptin levels. DAF-2DA staining was absent in PVAT from ob/ob mice but was detected in these animals after 4-wk leptin replacement. The main finding in this study is that adaptative NO overproduction occurs in PVAT during early DIO which might be aimed at preserving vascular function. (Endocrinology 151: 0000 -0000, 2010) O besity is an independent risk factor for the development of endothelial dysfunction and vascular disease. Indeed, some studies ensure that the probability of suffering from vascular diseases is four times higher in obese people (body mass index Ͼ30 kg/m 2 ) than in normal-weight people (body mass index Յ25 kg/m 2 ) (1). Adipose tissue is now considered a highly active endocrine organ (2) that releases a variety of inflammatory cytokines, adipokines, and other factors which might influence vascular tone (3) (4) (5) (6) . In the last years, several studies have demonstrated that the adipose tissue surrounding blood vessels, termed as perivascular adipose tissue (PVAT), has a paracrine role in the regulation of vascular function (7) (8) (9) . Under physiological conditions, PVAT releases a number of adipokines, such as adipocyte-derived relaxing factor (10 -14) , adiponectin (15) , Ang 1-7 (16), H 2 O 2 (14) , or leptin (17) , that elicit a beneficial anticontractile effect on vascular function and are essential for the maintenance of vascular resistance (9) . Interestingly, the anticontractile effect of PVAT is directly dependent on the amount of periadventitial fat (11, 13) . Reduction of PVAT mass in lean animals correlates with increased contractile responses in mesenteric artery rings and with a lower release of vasodilatory adipokines (13) . The anticontractile effect of PVAT has been also observed in human arteries, such as the thoracic artery (18, 19) , leading to the question whether re-moval of PVAT for coronary artery bypass might be deleterious for the graft patency (19 -22) . Consequently, in situations of normal weight, PVAT has a protective and beneficial role that is directly related to its amount.
PVAT size appears to be increased in obese humans (23) as well as in animal models of obesity (15, 24, 25) . Thus, PVAT would contribute to preserve vascular anticontractile responses in these individuals. However, there is evidence that adipokine production in obesity is unbalanced in favor of vasoconstrictor and proinflammatory substances (9) . Gao et al. (26) demonstrated that the anticontractile effect of PVAT appears to be lost in an animal model of obesity despite higher amounts of PVAT. Similarly, New Zealand obese mice, which develop severe metabolic syndrome associated with hypertension (27) , show a reduced anticontractile effect of PVAT (15) together with increased superoxide production and reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity (25) . Interestingly, some of these alterations are reversed by restoring the adipokine balance, as demonstrated in ob/ob mice with leptin replacement (28) . Therefore, a crucial question that remains to be addressed is to determine the time point during obesity development when PVAT switches from a protective to a deleterious influence.
It is well known that fat-enriched diets trigger initial compensatory mechanisms in adipose tissue aimed at preventing organ damage and lipotoxicity (29 -31) . Our hypothesis is that PVAT enlargement is integral to this general adaptation aimed, in this case, at preserving vascular function. Therefore, the aim of the current study was to assess vascular function at early states of diet-induced obesity (DIO) in mice. With this goal, we have determined the effect of 8-wk HF diet in the whole perfused mesenteric vascular bed (surrounded by PVAT) and in isolated mesenteric arteries cleaned of PVAT. We have analyzed (1) endothelium-dependent relaxation, (2) endothelium-independent relaxation, (3) NO bioavailability in the endothelium and in PVAT, and (4) leptin contribution to these responses.
Materials and Methods

Animals and dietary treatment
Four-week-old male C57BL/6J mice (Harlan, Barcelona, Spain) weighing 16 -18 g were housed under controlled light (12-h light, 12-h dark cycles from 0800 h to 2000 h) and temperature (22-24 C) conditions with standard food and water ad libitum. After 1 wk, animals with similar average body weight were divided into two groups and housed eight to 10 per cage and assigned either to a normal diet or to a high-fat diet. Control diet (D12450B, 10 kcal % fat, 70 kcal% carbohydrates and 20 kcal % protein; 3.85 kcal/g) or high-fat diet (D12451, 45 kcal % fat, 35 kcal % carbohydrates, 20 kcal % protein; 4.73 kcal/g) were supplied by Research Diets (New Brunswick, NJ) and will be referred to as LF and HF, respectively. HF and their respective LF control mice had free access to food during 8 wk.
Four-week-old male leptin-deficient obese mice (Charles River, Barcelona, Spain), referred as ob/ob, were used to determine the contribution of leptin and PVAT to alterations in vascular function. Mice were housed under controlled light (12- On the last day, mice were weighed and killed by decapitation between 0800 and 0900 h. Blood was collected in chilled EDTAcoated polypropylene tubes and the mesenteric bed (MB) was immediately dissected. For mesenteric adipose tissue isolation and quantification, the whole mesentery was removed and the intestine was carefully dissected. The whole MB was weighed. Lumbar adipose tissue, also known as retroperitoneal fat pad, is placed along the dorsal wall of the abdomen and surrounding the kidney. Because this is paired, we dissected and weighed both pads. Plasma samples were frozen for biochemical determinations and mesenteric arteries were used for both vascular function and confocal imaging studies. The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the United States National Institutes of Health (NIH publication no. 85-23, revised 1996).
Plasma measurements
Plasma leptin and adiponectin concentrations were analyzed by specific RIA for murine leptin (Linco Research, Billerica, MA; 4.9% intraassay variation, 3.3% interassay variation) and adiponectin (Linco Research; 4.43% intraassay variation, 7.13% interassay variation). Insulin was determined by means of a specific EIA kit for mouse insulin (Mercodia, Denmark; 2.2% intraassay variation, 4.9% interassay variation). Glucose was measured by a spectrophotometric method (Glucose Trinder Method; Roche, Madrid, Spain). Triglycerides and nonesterified free fatty acids were determined using the GPO (Biolabo, Maizy, France) and ACS-ACOD (Wako, Neuss, Germany) methods, respectively.
Vascular reactivity in the perfused mesenteric vascular bed
The superior mesenteric artery was cannulated at its junction with the abdominal aorta. The MB was separated from the intestine, placed in an organ chamber, and perfused using a peristaltic pump (Ismatec, Barcelona, Spain) at constant flow (1.5 ml/min) with oxygenated (95% O 2 /5% CO 2 ) Krebs-Henseleit solution (KH: 115 mM NaCl, 4.6 mM KCl, 2.5 mM CaCl 2 , 25 mM NaHCO 3 , 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 0.01 mM EDTA, 11.1 mM glucose). Perfusion pressure was monitored by a pressure transducer (Grass) and recorded by BIOPACK software. Bubbles in the perfusion buffer were removed by a bubble trap system, and flow was kept at constant rate. Changes in perfusion pressure were used as an index of changes in artery resistance, and therefore increase or decrease of perfusion pressure was indicative of vasoconstriction or vasodilatation, respectively. After equilibration (40 min), vascular contractility was assessed with KCl (75 mM). Relaxant response to acethylcholine (Ach) and sodium nitroprusside (SNP) were analyzed in the MB, precontracted with 10
methylester (L-NAME) and 1H-(1,2,4)oxadiazolo(4,3-␣)quinoxalin-1-one (ODQ) were preincubated for 20 min.
Vascular reactivity in isolated mesenteric arteries cleaned of PVAT
First-order branches of mesenteric arteries were disssected, cleaned of PVAT, and cut in 2-mm segments. Arteries were mounted on 25-m wires in a wire myograph (Danish Myotech, Aarhus, Denmark). After 30 min of previous incubation, vessel wall tension and diameter were normalized following a standardized method described by Mulvany and Halpern (32) . Afterwards, segments were washed with KH solution and stabilized for 30 min. After equilibration, vascular contractility was assessed with KCl (75 mM). Relaxant response to Ach and SNP were analyzed in mesenteric arteries, precontracted with 10 Ϫ6 M NA. L-NAME was preincubated for 20 min.
Determination of cyclic GMP levels
Mesenteric arteries, cleaned of PVAT, were preincubated at 37 C for 30 min in oxygenated (95% O 2 -5% CO 2 ) KH solution containing zaprinast (10 Ϫ5 M), an inhibitor of phosphodiesterase, to prevent cyclic GMP (cGMP) degradation. Afterwards, arteries were incubated with 10 Ϫ6 M SNP for 2 min, then homogenated with ethanol/water (2/1) and centrifuged at 4 C (20 min, 100,000 ϫ g). Positive controls were incubated with 8-bromo-cGMP (10 Ϫ6 M) and handled as described. Dry pellets were reconstituted in Tris-EDTA buffer and used for cGMP assay. Measurements were made by using a cGMP RIA kit (Amersham, Spain) as described in the manufacturer's instructions. Data were expressed as picomoles cGMP/milligram of protein. Proteins were determined by the Bradford method (33).
Determination of basal nitric oxide availability by confocal microscopy
Nitric oxide (NO) availability was determined by using the fluorescent NO indicator 4,5-diaminofluorescein diacetate (DAF-2DA), as previously described (34) . Briefly, mesenteric arteries were immediately dissected, cleaned of adipose tissue, and stabilized in KH (30 min, 37 C), then stained with DAF-2DA (10 Ϫ5 M) and washed with KH in the darkness in a shaking bath (30 min, 37 C). Negative and positive controls were incubated with either 10 Ϫ4 M L-NAME or 15 U/ml superoxide dismutase (SOD), respectively. Thereafter, segments were washed 2 ϫ 15 min in KH, fixed in 4% paraformaldehyde, and 3-mm segments mounted. Under our conditions paraformaldehyde fixation did not affect DAF-2DA fluorescence (35) . In addition, segments containing intact perivascular fat were incubated with DAF-2DA to determine NO production from mesenteric adipose tissue. Confocal projections of the mesenteric artery were then obtained and intensity levels quantified with Metamorph image analysis software (Universal Imaging Corporation, Buckinghamshire, UK).
Materials
Ach was dissolved in saline. NA and SNP were dissolved in 0.01% ascorbic acid/saline. L-NAME, SOD, and 8-bromocGMP were dissolved in distilled water. Zaprinast was dissolved in PBS. ODQ was dissolved in 50% dimethylsulfoxide (final concentration of dimethyl sulfoxide was less than 0.1% in PBS). All chemicals were provided by Sigma (St. Louis, MO) with the exception of ODQ (Tocris Cookson, Bristol, UK).
Statistics
All values are given as mean Ϯ SEM. Statistical significance was analyzed by one-way ANOVA followed by Newman-Keuls post hoc test. Statistical significance was set at P Ͻ 0.05. n represents the number of data. Contractions are expressed in mm Hg in the perfused MB, and in mN in isolated mesenteric arteries. Relaxations are expressed as the percentage of a previous NA contraction. The maximum response (E max values) and the negative logarithm of concentration producing 50% of maximum response (pD 2 values) were calculated by a nonlinear regression analyze of each individual concentration-response curve.
Results
Body weight, adiposity, and plasma parameters
As summarized in Table 1 , both HF and ob/ob animals weighed significantly more than LF. In addition, weight of lumbar adipose tissues, expressed in mg per mm tibial length, was 5.2-fold higher in HF and 8.8-fold higher in ob/ob than in the LF group. Mesenteric adipose tissue increase was of 1.3-fold in HF and 3-fold in ob/ob compared with LF.
Plasma biochemical parameters (Table 2) were not modified by dietary treatment, with the exception of leptin which exhibited a 296% increase in HF animals. Moreover, plasma leptin concentration positively correlated with the amount of adipose tissue (F (1,9) ϭ 28.9, P Ͻ 0.001; r ϭ 0.88; data not shown). Plasma leptin in control and leptin-supplemented ob/ob mice were undetectable and 10.1 ng/ml, respectively.
Endothelial NO release is not modified by HF diet
Endothelium-dependent relaxation was analyzed in first-order branches of mesenteric arteries cleaned of PVAT. As shown in Fig. 1A , relaxation to Ach (10 Ϫ9 -10 Ϫ4 M) was unmodified by HF. No differences between groups were observed in either E max (84.9 Ϯ 2.9% in LF vs. 78.7 Ϯ 4.3% in HF) or pD 2 (6.3 Ϯ 0.3 in LF vs. HF ϭ 6.3 Ϯ 0.1 in HF). Moreover, inhibition of endothelial-dependent relaxation elicited by 10 Ϫ4 M L-NAME was also similar in LF and HF animals ( Fig. 1A ; E max ϭ 39.1 Ϯ 4.9% and pD 2 ϭ 5.5 Ϯ 0.2 vs. E max ϭ 39.2 Ϯ 4.7% and pD 2 ϭ 5.9 Ϯ 0.2 in LF and HF, respectively). Basal contraction to L-NAME was not different between groups (LF ϭ 0.24 Ϯ 0.2% vs. HF ϭ 0.21 Ϯ 0.1%). Endothelial NO availability, determined by confocal microscopy in mesenteric arteries cleaned of PVAT, was similar between LF and HF animals (Fig. 1, B and C) . No differences were observed when arteries were preincubated with 15 U/ml SOD, to avoid superoxide-induced inactivation of NO (results not shown).
Preincubation with 10
Ϫ4 M L-NAME reduced fluorescence intensity in a similar extent both in LF and HF animals (results not shown). All the precedent data indicate that 8-wk HF does not induce changes in endothelial NO release.
Smooth muscle sensitivity to NO is not modified by HF diet
To analyze the sensitivity of mesenteric smooth muscle to NO, concentration-response curves to SNP (10
NO donor, were performed in first-order branches of mesenteric arteries cleaned of PVAT. As shown in Fig. 1D also similar between groups (Fig. 1E) . These data indicate that the sensitivity of guanilylcyclase to NO is not modified because of HF.
Effect of HF on MB function
We used the whole MB to evaluate the influence of PVAT on vascular function after 8 wk of HF feeding. A perfusion flow rate of 1.5 ml/min was chosen according to previous experiments showing that maximal contraction to 75 mM KCl are obtained at this flow (results not shown).
Basal perfusion pressure was similar between groups (LF ϭ 15. Cumulative doses of Ach (10
Ϫ9
-10 Ϫ4 M) elicited a concentration-dependent relaxation in both groups. As shown in Fig. 2A , relaxation was shifted to the left the HF group [oneway ANOVA, F (1,161) ϭ 8.095, P Ͻ 0.01]. E max and pD 2 values are shown in Table 3 . The effect of 10 Ϫ4 M L-NAME on Ach-induced relaxation was more pronounced in LF ( Fig. 2A and Table 3 ). Indeed, the inhibition by L-NAME of Ach-response was 61.4 Ϯ 6.3% in LF vs. 23.7 Ϯ 5.1% in HF. Cumulative concentration-response curves to SNP (10 Ϫ12 to 10 Ϫ5 M) were shifted to the left in HF animals
[one-way ANOVA, F (1, 56) ϭ 59.032, P Ͻ 0.001; Fig. 2B ].
The inhibitor of guanylylcyclase, ODQ (10 Ϫ5 M), significantly inhibited SNP-induced relaxation in both groups. However, the shift to the left was maintained.
Effect of HF on NO availability in PVAT
Production of NO in mesenteric PVAT was determined by means of confocal microscopy. As illustrated in Fig. 3 , A-C, fluorescence intensity was 3-fold higher in mesenteric adipocytes of the HF group compared with the LF group. Furthermore, a positive correlation was found between DAF-2DA fluorescence and plasma leptin concentration of LF and HF animals ( Fig. 3D ; r ϭ 0.928; F (10, 11) ϭ 62.352; P Ͻ 0.001).
Role of leptin on increased NO availability in PVAT
To elucidate the eventual role of leptin in NO overproduction in mesenteric PVAT of HF animals, we determined NO availability in mesenteric PVAT of ob/ob mice, which lack leptin production. As expected, confocal projections showed a small DAF2-DA staining in mesenteric adipocytes of ob/ob mice (Fig. 3E) . Leptin administration by means of sc osmotic Alzet minipumps (4 wk) significantly enhanced DAF2-DA fluorescence in mesenteric PVAT (Fig.  3F) . Altogether, these results show that the increased production of NO in mesenteric PVAT of HF animals might be related to diet-induced hyperleptinemia.
Discussion
In this study, we show a moderate enlargement of PVAT during early DIO which correlates with NO overproduction in this tissue and also with a rise in plasma leptin. We suggest that these changes might be integral to the general adaptation observed at initial steps of HF feeding probably aimed at preserving vascular function.
Feeding mice with chow enriched with saturated fat gradually leads to overweight, hyperleptinemia, and obesity. In the current study we use the term early DIO to refer to the metabolic status induced by 8-wk dietary treatment with HF diet, which is characterized by increased adiposity (overweight rather than obesity) and hyperleptinemia, but preserves peripheral responsiveness to leptin, as well as normal postprandrial values of adiponectin, insulin, glucose, triglycerides, and free-fatty acids (36).
Although overweight and obesity usually deal with alterations of vascular function, as observed in experimental models of DIO (37) and in ob/ob mice (Ref. 28 and Fig.  1A ), an enhancement of vascular function in early DIO has been also described (38, 39) . In the current study, despite increased visceral adiposity, we observed an enhancement of vasodilatory responses in the whole perfused MB. To characterize the underlying mechanisms, we first investigated in isolated mesenteric arteries of HF animals a pos- sible increase of endothelial NO availability. Because both DAF2-DA staining as well as Ach-induced relaxation were similar between groups, it is concluded that 8-wk HF diet does not affect endothelial NO release. Moreover, an increased sensitivity to the vasodilatory effect of NO, previously reported to occur in obesity (38, 39) , can also be discarded as differences between groups in SNP-induced relaxation and in cGMP concentration were not detected. These results demonstrate that the sensitivity and/or activity of guanilylcyclase to NO are not modified because of HF. The most relevant result in the current study is the overproduction of NO by mesenteric PVAT in HF mice. As illustrated in Fig. 2 and Table 3 , shifting to the left of concentration-response curves for Ach and SNP in the whole perfused MB from HF suggests that PVAT might be an additional source of NO in HF mice. Such a possibility is supported by the finding that in absence of PVAT the response to these drugs in isolated mesenteric arteries is identical in both groups. Moreover, our result is consistent with previous studies showing that both inducible and endothelial isoforms of NO synthase are expressed in adipocytes (5, 6, 40) and appear to be up-regulated in obesity (3). An additional support for the role of PVAT-derived NO is yielded by the effect of L-NAME and ODQ in the whole MB. As these drugs are perfused intraluminally, they do not reach PVAT and thus appear to be unable to block adipose NO production and its effects. Therefore, it is NO from PVAT which accounts for the difference between LF and HF (Fig. 2) . Interestingly, overproduction of NO is not linked to larger amounts of PVAT as the increase of NO observed in HF animals was not detected in agematched ob/ob mice. From our results, we suggest that compensatory mechanisms in adipose tissue at initial steps of DIO or during temporary/seasonal overweight (i.e. hibernator mammals) aimed at preventing organ damage and lipotoxicity (29 -31) might also include an adaptation of PVAT to protect, in this case, vascular function.
A main question raised by our data concerns the mechanism responsible for NO production in PVAT of HF mice. We detected a positive correlation between NO production by mesenteric PVAT and plasma leptin levels suggesting an effect of leptin in regulating NO production in perivascular adipocytes. Therefore, and aiming to elucidate the involvement of leptin in NO overproduction, we analyzed NO availability in mesenteric PVAT of ob/ob mice before and after leptin replacement. As expected, NO was almost absent in untreated ob/ob mice but significantly increased by leptin administration. Mehebik et al. (41) demonstrated that leptin induced a rapid increase of NO synthase activity in white adipocytes, which was mediated by phosphorylation of Ser 1179 and Thr 497 by JAK2, PKA, and MAPKs. Therefore, our results allow suggesting that NO overproducion in PVAT might be triggered by the moderate diet-induced hyperleptinemia in HF mice.
Hyperleptinemia has been considered a cause of cardiovascular and metabolic disorders linked to obesity. This concept, triggered by initial research showing that leptin inhibits both insulin secretion and lipogenic activity in white adipose tissue, has already been overcome, and hyperleptinemia is currently considered as an adaptive response to prevent metabolic alterations linked to overfeeding. Special attention has to be paid to a number of works by RH Unger (reviewed in Refs. 29 -31) , suggesting that fat-enriched diets trigger initial compensatory mechanisms in adipose tissue to avoid lipotoxicity in nonadipose tissues. Although some studies have linked chronic hyperleptinemia to endothelial dysfunction and damage (42-44), here we suggest that hyperleptinemia evoked by the moderate increase of adiposity during early DIO accounts for NO overproduction in mesenteric PVAT leading to a paracrine improvement of vascular function. Therefore, we conclude that PVAT is integral to the general adaptation observed in adipose tissues at initial steps of HF feeding aimed, in this case, at preserving vascular function.
In conclusion, this is the first study demonstrating NO production in PVAT with a paracrine role on mesenteric vascular function. Moreover, we suggest that the rise in plasma leptin during early DIO might allow the adaptation of PVAT to prevent vascular damage.
